CommercialCoverageMedium impact
Outpatient Coverage of Remdesivir for COVID-19 for all CareFirst Members
CareFirst BlueCross BlueShield·Infectious Disease, Emergency Medicine, Internal Medicine +1 more·Provider News
Effective date
Jan 12, 2022
We identified it
Jun 20, 2026
Summary
CareFirst is now covering outpatient Remdesivir (VEKLURY) infusions for COVID-19 treatment from January 12 through February 15, 2022, with no prior authorization required. Use HCPCS code J0248 for billing outpatient Remdesivir administration.
Action Required
Immediately: Billing team must verify HCPCS code J0248 is set up in billing system for outpatient Remdesivir infusions. Update encounter forms to include J0248 for COVID-19 outpatient treatment. Apply normal cost sharing and benefit limitations - no prior authorization required for CareFirst members through February 15, 2022.